Anebulo Pharmaceuticals (ANEB) Net Income towards Common Stockholders (2020 - 2025)
Anebulo Pharmaceuticals (ANEB) posted Net Income towards Common Stockholders of -$2 million for fiscal Q2 2026 (quarter ended Dec 31, 2025), compared with -$2.46 million a year earlier.
Powered by 
Analysis
Anebulo Pharmaceuticals (ANEB) Net Income towards Common Stockholders (2020 - 2025) Analysis & Trends
For the trailing twelve months through Dec 31, 2025, Net Income towards Common Stockholders at Anebulo Pharmaceuticals was -$7.99 million; for FY2025 (ended Jun 30, 2025), it was -$8.5 million.
- In prior fiscal years, Anebulo Pharmaceuticals' Net Income towards Common Stockholders was -$8.2 million in FY2024, -$11.73 million in FY2023, -$6.83 million in FY2022 and -$38.46 million in FY2021.
- Quarterly Net Income towards Common Stockholders has run from a low of -$29.11 million in fiscal Q4 2021 to a high of -$1.07 million in fiscal Q2 2022 over five years.
- According to Business Quant data, Net Income towards Common Stockholders for the three prior fiscal quarters was -$2.16 million (Q1 2026), -$2.16 million (Q4 2025) and -$1.68 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Anebulo Pharmaceuticals | 13.15 Mn | 13.15 Mn | - | -2.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -2.00 Mn |
| Sep 30, 2025 | -2.16 Mn |
| Jun 30, 2025 | -2.16 Mn |
| Mar 31, 2025 | -1.68 Mn |
| Dec 31, 2024 | -2.46 Mn |
| Sep 30, 2024 | -2.20 Mn |
| Jun 30, 2024 | -1.35 Mn |
| Mar 31, 2024 | -1.65 Mn |
| Dec 31, 2023 | -2.72 Mn |
| Sep 30, 2023 | -2.48 Mn |
| Jun 30, 2023 | -2.50 Mn |
| Mar 31, 2023 | -2.80 Mn |
| Dec 31, 2022 | -3.83 Mn |
| Sep 30, 2022 | -2.61 Mn |
| Jun 30, 2022 | -2.32 Mn |
| Mar 31, 2022 | -1.88 Mn |
| Dec 31, 2021 | -1.07 Mn |
| Sep 30, 2021 | -1.55 Mn |
| Jun 30, 2021 | -29.11 Mn |
| Mar 31, 2021 | -8.76 Mn |
API Access
Anebulo Pharmaceuticals Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=ANEB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "ANEB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=ANEB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();